Eli Lilly and Co (LLY)
781.10
+43.90
(+5.96%)
USD |
NYSE |
Apr 30, 16:00
773.30
-7.80
(-1.00%)
Pre-Market: 04:22
Eli Lilly Cash from Investing (TTM): -7.153B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.153B |
September 30, 2023 | -5.172B |
June 30, 2023 | -3.047B |
March 31, 2023 | -3.414B |
December 31, 2022 | -3.763B |
September 30, 2022 | -3.304B |
June 30, 2022 | -2.965B |
March 31, 2022 | -2.622B |
December 31, 2021 | -2.868B |
September 30, 2021 | -3.057B |
June 30, 2021 | -2.754B |
March 31, 2021 | -2.482B |
December 31, 2020 | -2.259B |
September 30, 2020 | -1.626B |
June 30, 2020 | -1.736B |
March 31, 2020 | -1.465B |
December 31, 2019 | -8.083B |
September 30, 2019 | -8.700B |
June 30, 2019 | -8.675B |
March 31, 2019 | -5.602B |
December 31, 2018 | 1.906B |
September 30, 2018 | 4.218B |
June 30, 2018 | 2.858B |
March 31, 2018 | -2.524B |
December 31, 2017 | -3.784B |
Date | Value |
---|---|
September 30, 2017 | -6.615B |
June 30, 2017 | -5.651B |
March 31, 2017 | -4.423B |
December 31, 2016 | -3.139B |
September 30, 2016 | -1.707B |
June 30, 2016 | -1.483B |
March 31, 2016 | -279.40M |
December 31, 2015 | 26.80M |
September 30, 2015 | -2.406B |
June 30, 2015 | -3.485B |
March 31, 2015 | -4.137B |
December 31, 2014 | -3.909B |
September 30, 2014 | -2.963B |
June 30, 2014 | -2.257B |
March 31, 2014 | -3.040B |
December 31, 2013 | -2.073B |
September 30, 2013 | -2.503B |
June 30, 2013 | -1.692B |
March 31, 2013 | -825.40M |
December 31, 2012 | -2.833B |
September 30, 2012 | -3.047B |
June 30, 2012 | -3.923B |
March 31, 2012 | -5.436B |
December 31, 2011 | -4.824B |
September 30, 2011 | -4.512B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-8.700B
Minimum
Sep 2019
-1.465B
Maximum
Mar 2020
-3.955B
Average
-3.047B
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Madrigal Pharmaceuticals Inc | -502.52M |
Vertex Pharmaceuticals Inc | -3.142B |
Viking Therapeutics Inc | -641.08M |
Moderna Inc | 4.206B |